Stocks cut or deleted early earnings on a fluctuating trading session on Thursday to give a mixed result. According to a report, stocks said that an experimental treatment for COVID-19 yielded disappointing results in an experiment. The producer of the treatment is Gilead Sciences Inc. GILD, -4.34%, later said that there are trial results for remdesivir "without results". Dow Jones Industrial Average DJIA, + 0.16% S&P 500 SPX, rose by 39 points or 0.2% compared to the preliminary figures, to close to 23,515. He lost 0.05% 1.5 points or increased 0.1% to approach 2,798. Nasdaq Composite COMP dropped by less than 0.1%, close to -0.00 to 8.495%. Shares of Gilead Sciences fell 4.3%.
11960
0
Stocks Mixed, Investors Evaluate Gilead Coronavirus Drug
Stocks cut or deleted early earnings on a fluctuating trading session on Thursday to give a mixed result. To a news
Yazar: Zack Smith
Yayınlanma: 24 Nisan 2020 14:41
Güncellenme: 6 Kasım 2024 23:00
Stocks Mixed, Investors Evaluate Gilead Coronavirus Drug
İLGİLİ HABERLER
European stocks soared and focus shifted to German retail sales after Powell's speech!
Forex Signal For TRY/USD: Inflation Slowdown in November.
Forex Signal For GBP/USD: Bullish Trend Still Not Breaking While Recovery Continues.
Forex Signal For EUR/USD: Starry US Data Points to Higher Fed Increases.
Forex Signal For BTC/USD: Downside Continues as Bitcoin Recovery Moves Less.
En Popüler Haberler
Yorum Yap
Yorumlar
Henüz yorum yapan yok! İlk yorumu siz yapın...